Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: September 6, 2026 at 1:44 PM UTC
| NCT Number | NCT07543055 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE1 |
| Target Enrollment | 36 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | August 28, 2026 (1 week ago) |
As of September 6, 2026: Clinical trial NCT07543055 is currently recruiting participants. This phase1 study for prostate cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07543055 is actively recruiting participants as of September 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07543055 was last updated 1 week ago (August 28, 2026). HelloStudys verifies this status automatically.